Dark Horse Consulting provides technical, CMC and regulatory solutions exclusively in the field of cell and gene therapy (“CGT”) within the broader life sciences industry. Dark Horse leverages its team of highly experienced consultants to help CGT clients achieve their strategic and operational objectives, spanning from high-level corporate strategy development to detailed technical implementation and regulatory roadmapping. DHC has a key focus on chemistry, manufacturing and controls (“CMC”) and regulatory strategy, offering services such as manufacturing support, process development, analytical development, quality management system analysis, device development, and regulatory support, among others.